REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Antigen, Epitope, Or Other Immunospecific Immunoeffector (e.g., Immunospecific Vaccine, Immunospecific Stimulator Of Cell-mediated Immunity, Immunospecific Tolerogen, Immunospecific Immunosuppressor, Etc.) > Allergen Or Component Thereof (e.g., Ragweed Pollen, Etc.) Allergen Or Component Thereof (e.g., Ragweed Pollen, Etc.)Allergen Or Component Thereof (e.g., Ragweed Pollen, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.08/02/07 - 20070178122 - Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same The present invention relates to fusion proteins comprising different allergens of the ns-LTPs family, and their use in the prevention and the treatment of allergic symptoms associated to said allergens. In particular, fusion proteins in the form of heterodimers comprising the major allergens of Parietaria judaica, Parj 1 and Parj ... 07/19/07 - 20070166335 - Allergy inhibitor compositions and kits and methods of using the same Compositions and kits for inhibiting an allergic response against an allergenic protein are disclosed. The compositions comprise a eukaryotic cell expression vector containing nucleotide sequences encoding an allergenic protein or a polypeptide that comprises an antigenic epitope of said allergenic protein; and an allergenic protein or a polypeptide that comprises ... 07/05/07 - 20070154496 - Dna sequence, and recombinant preparation of the grass pollen allergen lol p4 The present invention relates to the provision of a DNA sequence of the major grass pollen allergen Lol p 4. The invention also encompasses fragments, new combinations of partial sequences and point mutants having a hypoallergenic action. The recombinant DNA molecules and the derived polypeptides, fragments, new combinations of partial ... 03/22/07 - 20070065468 - Chimeric allergens for immunotherapy The present invention provides a chimeric polypeptide for reducing specific IgE binding to at least two house dust mite allergens in a subject, said chimeric polypeptide comprises an amino acid sequence comprising sequences of said at least two house dust mite allergens and wherein upon exposure to said allergens, said ... 03/22/07 - 20070065467 - Immunostimulatory nucleic acid molecules for activating dendritic cells The present invention relates generally to methods and products for activating dendritic cells. In particular, the invention relates to oligonucleotides which have a specific sequence including at least one unmethylated CpG dinucleotide which are useful for activating dendritic cells. The methods are useful for in vitro, ex-vivo, and in vivo ... 01/04/07 - 20070003580 - Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound The present invention relates to an anti-allergic pharmaceutical composition containing at least two active agents chosen from: (i) one allergen, (ii) one antihistamine compound, and (iii) one inhibitor of histamine synthesis, said active agents being associated in said composition with a pharmaceutically acceptable vehicle. ... 01/04/07 - 20070003579 - Allergen-specific immunotherapy Heat-denatured allergen compositions of bee venom, grass pollen, birch pollen, and cat dander or hair for use in allergen-specific immunotherapy. ... 12/28/06 - 20060292182 - Photoadjuvant immunotherapy A photoadjuvant immunotherapeutical method includes the steps of providing a phototherapeutical apparatus, comprising a light source, an optical guidance system, and a patient interface; determining a minimal erythema dose; performing phototherapy by irradiating a target surface with the phototherapeutical apparatus; and performing immunotherapy by exposing the irradiated target surface to ... 11/30/06 - 20060269577 - Allergy inhibition Allergen contact with a person's allergen-responsive tissues is reduced by removing airborne allergens from body surfaces adjacent the person's eyes. Airborne allergens may be removed from body surfaces adjacent the person's eyes by irrigating such areas with an irrigating fluid or by wiping such areas with a pad. Preferably the ... 11/30/06 - 20060269576 - Non-injection immunotherapy Methods and compositions are disclosed for the reduction of immune responses to an exogenous allergen. The reduction is obtained by pre-treatment or pre-conditioning, without injection, of a subject with the allergen so as to reduce immune responses in the subject upon additional exposure to the allergen. The invention is advantageously ... 11/23/06 - 20060263391 - Process for the preparation of hypoallergenic mosaic antigens A process for the preparation of an hypoallergenic mosaic antigen derived from an allergen is disclosed whereby a) in a first step the allergen is split into at least two parts and the IgE reactivity of each part is determined and b) in a second step those parts of the ... 11/09/06 - 20060251682 - Variants of the major allergen phl p 1 from timothy grass The invention relates to pharmaceutically important variants of the major allergen Phl p 1 from timothy grass, characterised in that a preparation, hitherto not possible, of monomeric molecules which are soluble and stable in physiological media can be carried out with the aid of prokaryotic expression systems and subsequent purification ... 10/19/06 - 20060233839 - Novel compounds The present invention provides a novel treatment for allergy comprising the provision of a recombinant Der p 1/ProDer p 1/PreProDer p 1 allergen derivative, ProDer p 3 or a recombinant ProDer p 3/Der p 3/PreProDer p 3 allergen derivative with hypoallergenic activity. Pharmaceutical compositions comprising said mutant allergens which stimulate ... 09/28/06 - 20060216315 - Cockroach allergen gene expression and delivery systems and uses The invention relates to compositions and methods for managing cockroach allergies in mammals. In particular aspects, the invention relates to the administration to a mammal of nucleic acids that encode a cockroach allergen. The compositions are prepared and administered in such a manner that the cockroach allergen coding sequence is ... 09/28/06 - 20060216314 - Hypoallergenic allergy vaccines based on the timothy grass pollen allergen phl p7 The present invention pertains to polypeptides derived from the timothy grass pollen allergen Phi p 7. The polypeptides display reduced allergen activity and are useful as allergy vaccines for treatment of sensitized allergic patients and for prophylactic vaccination. ... 09/21/06 - 20060210590 - Minor allergen control to increase safety of immunotherapy The invention discloses a method for standardizing allergen extract with respect to the contents of major as well as minor allergens. The method comprises determining relative amounts of allergens in a given extract, followed by an adjustment of the contents of major an minor allergens so as to meet predefined ... 08/10/06 - 20060177470 - Dna sequence and recombinant production of the grass pollen allergen phl p4 The present invention relates to the provision of the genetic sequence of the major grass pollen allergen Phl p 4. The invention also covers fragments, new combinations of partial sequences and point mutants having a hypoallergenic action. The recombinant DNA molecules and the derived polypeptides, fragments, new combinations of partial ... 08/03/06 - 20060171968 - Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine The present invention relates to a method of preventive treatment of allergy to an allergen in a subject comprising a) administering an allergy vaccine containing the allergen as active substance to the subject via an oromucosal route, b) wherein the subject to be treated is unsensitised in the sense of ... 07/13/06 - 20060153882 - Anti-allergic pharmaceutical composition containing at least one allergen and at least on antihistamine compound The present invention relates to an anti-allergic pharmaceutical composition containing at least two active agents chosen among: (i) one allergen, (ii) one antihistamine compound, (iii) one inhibitor of histamine synthesis, said active agents being associated in said composition with a pharmaceutically acceptable vehicle. ... 06/08/06 - 20060121064 - Method of preventive treatment of allergy by mucosal administration of an allergy vaccine The present invention relates to a method of preventive treatment of allergy to an allergen in a subject comprising administering an allergy vaccine containing the allergen as active substance to a mucosal surface of the subject, a) wherein the subject to be treated is sensitised so as to exhibit an ... 06/08/06 - 20060121063 - Group 2 mite polypeptide variants This invention concerns variants of group 2 mite polypeptides, wherein the polypeptide of the variant comprise one or more mutations in the positions or corresponding to the positions consisting of D64, V40, E53, S57, K82, G83, I97 of SEQ ID NO: 1 or 64, 40, 53, 57, 82, 83, 97 ... 06/08/06 - 20060121062 - Conjugated hydroxyalkyl starch allergen compounds The invention relates to a conjugated compound of hydroxyalkyl starch and an allergen, in which at least one hydroxyalkyl starch is covalently coupled to the allergen. ... 06/01/06 - 20060115499 - Liquid allergy vaccine formulation for oromucosal administration Use of a composition comprising an allergen and an adjuvant selected from the group consisting of oxygen-containing metal salts for the manufacture of a liquid formulation for preventing or treating allergy in a subject by oromucosal administration, and a method of preventing and treating allergy in a subject by oromucosal ... 02/02/06 - 20060024334 - Immunotherapeutic methods and systems Methods for desensitising an individual to a selected polypeptide antigen are provided. The methods entail administration of T cell epitope containing peptides from a polypeptide antigen in such a way as to establish a tolergeneic environment, that is, a state of hyporesponsiveness to the peptides. The selected polypeptide antigen is ... 01/05/06 - 20060002962 - Method of treating allergy and infection by eliciting an iga antibody response The invention relates to a method of preventing or treating an allergy to or an infection by a mucosal antigenic agent in a subject comprising a) subjecting the subject to a priming treatment by means of parenteral or adjuvant-facilitated mucosal administration to activate the systemic immune system, and b) subjecting ... 08/11/05 - 20050175638 - Methods and compositions for dosing of allergens The present invention comprises methods and compositions for immunotherapy. An aspect of the invention comprises administration of one or more allergens in compositions via oral and sublingual routes. Allergen compositions are administered in dosing intervals wherein the increase in the one or more allergens administered to the patient are provided ... 07/14/05 - 20050152927 - Allergenic proteins and peptides from japanese cedar pollen The present invention provides nucleic acid sequences coding for the Cryptomeria japonica major pollen allergen Cry j I, Cry j II, Jun s I and Jun v I and fragments or peptides thereof. The present invention also provides purified Cry j I, Cry j II, Jun s I and Jun ... 06/09/05 - 20050123570 - Allergen formulation Provided is a pharmaceutical composition comprising tyrosine, an optionally modified allergen, and 3-DMPL, the is useful in the prevention and treatment of allergies. ... 06/09/05 - 20050123569 - Nucleic acids encoding a house dust mite allergen der p iii, and uses therefor Isolated nucleic acids encoding an allergen of Dermatophagoides pteronyssinus, Der p III, are disclosed. A cDNA encoding a peptide having a Der p III activity and a predicted molecular weight of about 24,985 daltons is also described. The nucleic acids can be used as probes to detect the presence of ... 06/09/05 - 20050123568 - Method for producing hypoallergenic major birch pollen allergen rbet v 1 The invention relates to a process for the preparation of hypoallergenic major birch pollen allergens by means of one or more chromatograpluc purification steps using essentially unbuffered aqueous bases as eluent and subsequent neutralisation. The hypoallergenic major birch pollen allergens are distinguished by a lack of, but at least by ... ### FreshPatents.com Support |